Kevin J. Harrington
凯文·哈林顿
MBBS, PhD, FRCP, FRCR
Professor of Biological Cancer Therapies生物癌症治疗学教授
👥Biography 个人简介
Kevin Harrington is a leading clinical oncologist and translational researcher specializing in head and neck cancer, oncolytic virotherapy, and radiobiology. He pioneered use of talimogene laherparepvec (T-VEC) in head and neck cancer and leads early-phase trials combining virotherapy with immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Oncolytic Virotherapy
Pioneered clinical development of T-VEC in head and neck cancer, establishing proof-of-concept for intratumoral viral immunotherapy in locoregional disease.
Radioimmunotherapy Combinations
Led seminal trials combining radiation with checkpoint inhibitors and viral immunotherapy agents, advancing multimodal treatment for HNSCC.
Representative Works 代表性著作
Preliminary Results of a Randomized, Open-Label Phase II Study of Nivolumab Alone or in Combination with Ipilimumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Annals of Oncology (2019)
Key combination immunotherapy data supporting dual checkpoint blockade in HNSCC.
Talimogene Laherparepvec versus Placebo in Head and Neck Squamous Cell Carcinoma
Journal of Clinical Oncology (2023)
Randomized trial evaluating intralesional T-VEC in HNSCC, informing future viral immunotherapy strategies.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Robert L. Ferris
University of Pittsburgh Medical Center
David J. Adelstein
Cleveland Clinic Taussig Cancer Institute
Maura L. Gillison
MD Anderson Cancer Center
Jean-Louis Lefebvre
Centre Oscar Lambret
关注 凯文·哈林顿 的研究动态
Follow Kevin J. Harrington's research updates
留下邮箱，当我们发布与 Kevin J. Harrington（Royal Marsden NHS Foundation Trust / Institute of Cancer Research）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment